SlideShare a Scribd company logo
5/21/2023 1
EPIDEMIOLOGY AND CONTROL OF
HYPERTENSION
5/21/2023 2
contents
• Introduction
• Problem statement
• Epidemiology
• Complications
• Diagnosis
• Prevention and control
• Treatment protocol
5/21/2023 3
INTRODUCTION
• Definition
–A systolic BP greater than 140 mm Hg or
–a diastolic BP greater than 90 mm Hg
• Types
–primary and secondary
5/21/2023 4
INTRODUCTION
• Silent killer
• Preventable and can be controlled
• Significant gaps in diagnosis and
treatment
5/21/2023 5
Problem statement
• Large burden- global and India
• Iceberg disease
5/21/2023 6
Global
• Prevalence doubled to 1.28 billion in last 3
decades
• Two- thirds in low and middle income countries
• Kills 8 million every year
5/21/2023 7
India
Overall prevalence – 22.7%
Kerala
Overall prevalence – 32%
[NFHS-5]
5/21/2023 8
Epidemiology
Non-modifiable risk
factors
• Age
• Sex
• Genetic factors
• Ethnicity
Modifiable risk factors
• Obesity
• Salt intake
• Saturated fat
• Dietary fibre
• Alcohol
• Physical activity
• Environmental stress
• Socioeconomic status
5/21/2023 9
COMPLICATIONS
5/21/2023 10
DIAGNOSIS
• BP measurement
– 2 readings
– Take third reading if differ by >5 mm Hg
– Lower reading of SBP and DBP taken
• Measuring BP
– Mercury sphygmomanometer / electronic digital
– Relax for 5 minutes
5/21/2023 11
5/21/2023 12
JNC 8 Classification
Prevention
Primary
prevention
Population
strategy
High-risk
strategy
Secondary
prevention
Early case
detection
Treatment
Tertiary
prevention
Patient
compliance
5/21/2023 13
Palliative
care
1 3 5
7
2
4 6
8
Whole community
Normotensive
subjects
Hypertensive
subjects
Undiagnosed Hypertension
Diagnosed Hypertension
Diagnosed and treated
Hypertension
Inadequately treated
Hypertension
Diagnosed but untreated Hypertension
Adequately treated
Hypertension
9
Rule of halves
5/21/2023 14
“Tracking” of blood pressure
5/21/2023 15
Primary Prevention
Population-strategy
small reduction in average
BP of a population
large reduction in
incidence of cardiovascular
complications
5/21/2023 16
Multifactorial
approach
•Nutrition
•Weight reduction
•Exercise promotion
•Behavioural changes
•Health education
•Self care
Primary Prevention
Life style Modifications
Modification Recommendation
Weight reduction Maintain normal body weight (BMI 18.5 -24.9)
DASH eating plan
(Dietary Approaches to
Stop Hypertension)
Diet rich in fruits, vegetables
Low sodium and low-fat diary products
Dietary sodium reduction Dietary sodium intake not more than 6 g NaCl
Physical activity Regular aerobic physical activity
Brisk walking atleast 30 minutes per day
Moderation of alcohol
consumption
Not more than two drinks per day
Stop smoking
5/21/2023 17
Primary Prevention
High – risk strategy
• Risk factors - low prevalence in the community
• Family history of hypertension
• “Tracking” of blood pressure
5/21/2023 18
Secondary Prevention
• Early case detection
– Screening
• Treatment
– Target blood pressure less than 140/90
• Patient compliance
– The extent to which patient behaviour
coincides with clinical prescription
5/21/2023 19
Category Systolic Diastolic
Optimal <120 <80
Normal 120 – 129 80 – 84
High normal 130 – 139 85 – 89
Grade 1
hypertension
140 – 159 90 – 99
Grade 2
hypertension
160 – 179 100 – 109
Grade 3
hypertension
≥180 >110
5/21/2023 20
Refer to
higher centre
ECG, S. Creatinine
Lifestyle modification
Drug treatment
Lifesyle
modification
5/21/2023 21
National Program for Prevention
and Control of Cancer,Diabetes
CVD and Stroke ( NPCDCS)
Objectives
• Prevent and control NCDs
• Early diagnosis and treatment
• Capacity building
• Palliative and rehabilitative care
5/21/2023 22
• NPCDCS renamed as
National Programme for Prevention and
Control of Non Communicable Diseases
NP-NCD
5/21/2023 23
Strategies
– Health promotion
– Population based Screening > 30 years
– Opportunistic screening > 30 years
– Non Communicable Disease (NCD) clinics
– Trained manpower
– Strengthening tertiary level facilities
– Service delivery – public health infrastructure
5/21/2023 24
5/21/2023 25
Indian Hypertension Control Initiative
– WHO, ICMR, MOHFW, State govts
– Target - 25% reduction in prevalence by 2025
– Decentralisation of essential health services
5/21/2023 26
51
66
0
20
40
60
80
2014 2015
HTN control rate (%),
2 pilot clinics
Protocols
Medication
Supply
Team
care
and
Task
sharing
Patient-
Centered
Care
Information
Systems
5/21/2023 27
https://www.linkedin.com/in/jazeela-mohamed-siddique-989976248

More Related Content

Similar to Hypertension.pptx

Diabetes and Cardiovascular Disease
Diabetes and Cardiovascular DiseaseDiabetes and Cardiovascular Disease
Diabetes and Cardiovascular Diseasescsinha
 
Ckd in kenya
Ckd  in  kenyaCkd  in  kenya
Ckd in kenya
MohamedKhamis77
 
Cardiovascular disease (CVD) Prevention: Importance and Barriers
Cardiovascular disease (CVD) Prevention: Importance and Barriers Cardiovascular disease (CVD) Prevention: Importance and Barriers
Cardiovascular disease (CVD) Prevention: Importance and Barriers
Dr. Bhartendu K Srivastava (PhD)
 
Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Diabetes and Aging: From Treatment Goals to Pharmacologic TherapyDiabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Ching-wen Lu
 
Diabetes Mellitus: Epidemiology & Prevention
Diabetes Mellitus: Epidemiology & PreventionDiabetes Mellitus: Epidemiology & Prevention
Diabetes Mellitus: Epidemiology & Prevention
Rizwan S A
 
Million-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptxMillion-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptx
derek462361
 
Hypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptxHypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptx
desktoppc
 
Approach to Hypertension - Combination therapy.pptx
Approach to Hypertension - Combination therapy.pptxApproach to Hypertension - Combination therapy.pptx
Approach to Hypertension - Combination therapy.pptx
drsbansal2000
 
ADA GUIDELINE.pptx
ADA GUIDELINE.pptxADA GUIDELINE.pptx
ADA GUIDELINE.pptx
SarathChandran576536
 
NON COMMUNICABLE DISEASE
NON COMMUNICABLE DISEASE NON COMMUNICABLE DISEASE
NON COMMUNICABLE DISEASE
PALAKNARULA7
 
CVD Risk asst Nursing lecture 2023.pdf
CVD Risk asst Nursing lecture 2023.pdfCVD Risk asst Nursing lecture 2023.pdf
CVD Risk asst Nursing lecture 2023.pdf
BatMan752678
 
The Hypertension Guidelines JNC 8
The Hypertension Guidelines JNC 8 The Hypertension Guidelines JNC 8
The Hypertension Guidelines JNC 8
Utai Sukviwatsirikul
 
AH and physical activity (1).pptx
AH and physical activity (1).pptxAH and physical activity (1).pptx
AH and physical activity (1).pptx
nithishkumar184
 
NCD Prevention in Cameroon
NCD Prevention in CameroonNCD Prevention in Cameroon
Hypertension Management
Hypertension Management Hypertension Management
Hypertension Management
Aparna Chaudhary
 
Non communicable disease
Non communicable diseaseNon communicable disease
Non communicable disease
Dalia El-Shafei
 
GI CANCER SCREENING
GI CANCER SCREENINGGI CANCER SCREENING
GI CANCER SCREENING
ChernHaoChong
 
diabetes update
 diabetes update  diabetes update
diabetes update
Mahmoud Abu Abed
 
Gliclazide in DKD - Case Study.pptx
Gliclazide in DKD - Case Study.pptxGliclazide in DKD - Case Study.pptx
Gliclazide in DKD - Case Study.pptx
AmeetRathod3
 
Presentation1 extra ppt
Presentation1 extra pptPresentation1 extra ppt
Presentation1 extra pptAneeqa Azad
 

Similar to Hypertension.pptx (20)

Diabetes and Cardiovascular Disease
Diabetes and Cardiovascular DiseaseDiabetes and Cardiovascular Disease
Diabetes and Cardiovascular Disease
 
Ckd in kenya
Ckd  in  kenyaCkd  in  kenya
Ckd in kenya
 
Cardiovascular disease (CVD) Prevention: Importance and Barriers
Cardiovascular disease (CVD) Prevention: Importance and Barriers Cardiovascular disease (CVD) Prevention: Importance and Barriers
Cardiovascular disease (CVD) Prevention: Importance and Barriers
 
Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Diabetes and Aging: From Treatment Goals to Pharmacologic TherapyDiabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
 
Diabetes Mellitus: Epidemiology & Prevention
Diabetes Mellitus: Epidemiology & PreventionDiabetes Mellitus: Epidemiology & Prevention
Diabetes Mellitus: Epidemiology & Prevention
 
Million-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptxMillion-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptx
 
Hypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptxHypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptx
 
Approach to Hypertension - Combination therapy.pptx
Approach to Hypertension - Combination therapy.pptxApproach to Hypertension - Combination therapy.pptx
Approach to Hypertension - Combination therapy.pptx
 
ADA GUIDELINE.pptx
ADA GUIDELINE.pptxADA GUIDELINE.pptx
ADA GUIDELINE.pptx
 
NON COMMUNICABLE DISEASE
NON COMMUNICABLE DISEASE NON COMMUNICABLE DISEASE
NON COMMUNICABLE DISEASE
 
CVD Risk asst Nursing lecture 2023.pdf
CVD Risk asst Nursing lecture 2023.pdfCVD Risk asst Nursing lecture 2023.pdf
CVD Risk asst Nursing lecture 2023.pdf
 
The Hypertension Guidelines JNC 8
The Hypertension Guidelines JNC 8 The Hypertension Guidelines JNC 8
The Hypertension Guidelines JNC 8
 
AH and physical activity (1).pptx
AH and physical activity (1).pptxAH and physical activity (1).pptx
AH and physical activity (1).pptx
 
NCD Prevention in Cameroon
NCD Prevention in CameroonNCD Prevention in Cameroon
NCD Prevention in Cameroon
 
Hypertension Management
Hypertension Management Hypertension Management
Hypertension Management
 
Non communicable disease
Non communicable diseaseNon communicable disease
Non communicable disease
 
GI CANCER SCREENING
GI CANCER SCREENINGGI CANCER SCREENING
GI CANCER SCREENING
 
diabetes update
 diabetes update  diabetes update
diabetes update
 
Gliclazide in DKD - Case Study.pptx
Gliclazide in DKD - Case Study.pptxGliclazide in DKD - Case Study.pptx
Gliclazide in DKD - Case Study.pptx
 
Presentation1 extra ppt
Presentation1 extra pptPresentation1 extra ppt
Presentation1 extra ppt
 

More from JazeelaMohamedSiddiq

AIDS.pptx
AIDS.pptxAIDS.pptx
SOCIAL ASPECTS OF NUTRITION.pptx
SOCIAL ASPECTS OF NUTRITION.pptxSOCIAL ASPECTS OF NUTRITION.pptx
SOCIAL ASPECTS OF NUTRITION.pptx
JazeelaMohamedSiddiq
 
Descriptive study.pptx
Descriptive study.pptxDescriptive study.pptx
Descriptive study.pptx
JazeelaMohamedSiddiq
 
ENTOMOLOGY- Mosquitoes.pptx
ENTOMOLOGY- Mosquitoes.pptxENTOMOLOGY- Mosquitoes.pptx
ENTOMOLOGY- Mosquitoes.pptx
JazeelaMohamedSiddiq
 
screening.pptx
screening.pptxscreening.pptx
screening.pptx
JazeelaMohamedSiddiq
 
Epidemiological Study Designs.pptx
Epidemiological     Study Designs.pptxEpidemiological     Study Designs.pptx
Epidemiological Study Designs.pptx
JazeelaMohamedSiddiq
 
GENETICS AND HEALTH.pptx
GENETICS AND HEALTH.pptxGENETICS AND HEALTH.pptx
GENETICS AND HEALTH.pptx
JazeelaMohamedSiddiq
 
MENTAL HEALTH.pptx
MENTAL HEALTH.pptxMENTAL HEALTH.pptx
MENTAL HEALTH.pptx
JazeelaMohamedSiddiq
 
HOSPITAL WASTE MANAGEMENT.pptx
HOSPITAL WASTE MANAGEMENT.pptxHOSPITAL WASTE MANAGEMENT.pptx
HOSPITAL WASTE MANAGEMENT.pptx
JazeelaMohamedSiddiq
 
DISASTER MANAGEMENT.pptx
DISASTER MANAGEMENT.pptxDISASTER MANAGEMENT.pptx
DISASTER MANAGEMENT.pptx
JazeelaMohamedSiddiq
 
Zika.pptx
Zika.pptxZika.pptx
HEPATITIS part 2.pptx
HEPATITIS part 2.pptxHEPATITIS part 2.pptx
HEPATITIS part 2.pptx
JazeelaMohamedSiddiq
 
OCCUPATIONAL HEALTH PART 2.pptx
OCCUPATIONAL HEALTH PART 2.pptxOCCUPATIONAL HEALTH PART 2.pptx
OCCUPATIONAL HEALTH PART 2.pptx
JazeelaMohamedSiddiq
 
OCCUPATIONAL HEALTH Part 1.pptx
OCCUPATIONAL HEALTH Part 1.pptxOCCUPATIONAL HEALTH Part 1.pptx
OCCUPATIONAL HEALTH Part 1.pptx
JazeelaMohamedSiddiq
 
KYASANUR FOREST DISEASE.pptx
KYASANUR FOREST DISEASE.pptxKYASANUR FOREST DISEASE.pptx
KYASANUR FOREST DISEASE.pptx
JazeelaMohamedSiddiq
 
VIRAL HEPATITIS.pptx
VIRAL HEPATITIS.pptxVIRAL HEPATITIS.pptx
VIRAL HEPATITIS.pptx
JazeelaMohamedSiddiq
 
NIPAH.pptx
NIPAH.pptxNIPAH.pptx
Voluntary health agencies ComMed.pptx
Voluntary health agencies ComMed.pptxVoluntary health agencies ComMed.pptx
Voluntary health agencies ComMed.pptx
JazeelaMohamedSiddiq
 

More from JazeelaMohamedSiddiq (20)

AIDS.pptx
AIDS.pptxAIDS.pptx
AIDS.pptx
 
SOCIAL ASPECTS OF NUTRITION.pptx
SOCIAL ASPECTS OF NUTRITION.pptxSOCIAL ASPECTS OF NUTRITION.pptx
SOCIAL ASPECTS OF NUTRITION.pptx
 
Descriptive study.pptx
Descriptive study.pptxDescriptive study.pptx
Descriptive study.pptx
 
ENTOMOLOGY- Mosquitoes.pptx
ENTOMOLOGY- Mosquitoes.pptxENTOMOLOGY- Mosquitoes.pptx
ENTOMOLOGY- Mosquitoes.pptx
 
screening.pptx
screening.pptxscreening.pptx
screening.pptx
 
Epidemiological Study Designs.pptx
Epidemiological     Study Designs.pptxEpidemiological     Study Designs.pptx
Epidemiological Study Designs.pptx
 
Rubella.pptx
Rubella.pptxRubella.pptx
Rubella.pptx
 
GENETICS AND HEALTH.pptx
GENETICS AND HEALTH.pptxGENETICS AND HEALTH.pptx
GENETICS AND HEALTH.pptx
 
MENTAL HEALTH.pptx
MENTAL HEALTH.pptxMENTAL HEALTH.pptx
MENTAL HEALTH.pptx
 
HOSPITAL WASTE MANAGEMENT.pptx
HOSPITAL WASTE MANAGEMENT.pptxHOSPITAL WASTE MANAGEMENT.pptx
HOSPITAL WASTE MANAGEMENT.pptx
 
DISASTER MANAGEMENT.pptx
DISASTER MANAGEMENT.pptxDISASTER MANAGEMENT.pptx
DISASTER MANAGEMENT.pptx
 
Zika.pptx
Zika.pptxZika.pptx
Zika.pptx
 
HEPATITIS part 2.pptx
HEPATITIS part 2.pptxHEPATITIS part 2.pptx
HEPATITIS part 2.pptx
 
OCCUPATIONAL HEALTH PART 2.pptx
OCCUPATIONAL HEALTH PART 2.pptxOCCUPATIONAL HEALTH PART 2.pptx
OCCUPATIONAL HEALTH PART 2.pptx
 
OCCUPATIONAL HEALTH Part 1.pptx
OCCUPATIONAL HEALTH Part 1.pptxOCCUPATIONAL HEALTH Part 1.pptx
OCCUPATIONAL HEALTH Part 1.pptx
 
KYASANUR FOREST DISEASE.pptx
KYASANUR FOREST DISEASE.pptxKYASANUR FOREST DISEASE.pptx
KYASANUR FOREST DISEASE.pptx
 
VIRAL HEPATITIS.pptx
VIRAL HEPATITIS.pptxVIRAL HEPATITIS.pptx
VIRAL HEPATITIS.pptx
 
NIPAH.pptx
NIPAH.pptxNIPAH.pptx
NIPAH.pptx
 
MEASLES.pptx
MEASLES.pptxMEASLES.pptx
MEASLES.pptx
 
Voluntary health agencies ComMed.pptx
Voluntary health agencies ComMed.pptxVoluntary health agencies ComMed.pptx
Voluntary health agencies ComMed.pptx
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 

Hypertension.pptx